Kv1.5 potassium ion channel inhibitors (AstraZeneca AB)

N/A

Report date: 2025/01/26 18:45:02
NME

Base Information

Drug NameKv1.5 potassium ion channel inhibitors (AstraZeneca AB)
Drug Alias NameAZ-13395438
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv1.5 blockers
TargetsVoltage-gated potassium channel subunit Kv1.5
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Ab
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Ab
Inactive CompaniesN/A
Active IndicationsAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A